Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
U&O Technologies markets the UAN.GO exoskeleton, the first Italian CE-certified exoskeleton for clinical and personal gait rehabilitation, offering both passive and active assisted robotic neuromotor therapy for individuals with limited lower limb mobility. Currently, there is no disclosed clinical trial data, but the product is available for clinical use and is marketed as supporting improved gait rehabilitation outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on U&O Technologies.